are considered responsible for the phenotype observed in their patients ( FEZF2 , CADPS , SYNPR , ATNX7 , PRICK-LE2 , and MAGI1 ). However, the authors underlined that a clear genotype-phenotype correlation is still not fully established and that the description of new clinical cases of deletions, restricted either to a single or a few genes, could be of great importance for this purpose.
We report the case of a small 500-kb proximal interstitial deletion in the 3p14.2 region, containing only a few genes, in a 60-year-old female. The patient has severe speech delay, mild ID, and slight facial dysmorphism, but no other major malformations. Our case was compared to previously described patients with overlapping deletions that presented similar clinical features.
The phenotype is suggested to be related to haploinsufficiency of the FEZF2 , CADPS , and PTPRG genes, supporting the hypothesis that a novel 3p14.2 core region in 3p proximal deletions is associated with neurodevelopmental disorders.
Case Report
The patient was a 60-year-old Italian woman. Her family history is unremarkable except for her mother's reported premature ovarian failure at 27 years of age ( Fig. 1 ) . Her parents are unrelated, and she is their only child, born at term by normal delivery after an uneventful pregnancy. Normal auxological parameters were present at birth: length 50 cm (25th centile), OFC 34 cm (25th centile), and weight 3,000 g (10-25th centile). Her physical development was normal during the neonatal period and infancy, and she had normal puberty. She presented with psychomotor developmental delay (sitting without support at 1 year) and severe speech delay with a limited number of words and very simple phrasing until she was about 9 years old. No neurological problems were detected and no motor deficits were present.
During her life, she did not suffer from severe health problems. She attended primary school until 13 years of age with special educational needs teachers and had difficulties with different simple employments (e.g., as a waitress and shop assistant). She was diagnosed as having mild ID. The patient had a healthy son. No miscarriages were reported. She suffered from premature ovarian failure at the age of 33.
Dysmorphology evaluation revealed a broad forehead, arched thick eyebrows, hypertelorism, wide bulbous nasal tip, short columella, a broad and large mouth with slightly downturned corners, thick lips, prominent chin, and brachydactyly of the hands ( Fig. 2 ). There was a small disproportion between span and height.
Methods

Genetic Analysis
A conventional chromosomal analysis (400 bands) was performed on the patient. We carried out a molecular analysis of the FMR1 gene by means of a PCR specific for the CGG trinucleotide repeat (Amplidex FMR1 PCR kit, Asuragen).
Following, we performed array CGH using standard procedures on a 4x44K slide (Cytochip oligo ISCA, Blugenome LTD) with a resolution of ∼ 150-250 kb and the results were confirmed by FISH using probes 368, 534, 278) Reference DNA was a normal human female genomic DNA. FISH analysis with the same specific probes used in the patient was performed on both her mother and her son, in order to confirm array-CGH results. A conventional chromosomal analysis was also performed on the patient's son.
Results
The karyotype was normal (46,XX). Molecular analysis of the FMR1 gene also was normal. Array-CGH analysis revealed a 500-kb deletion in the 3p14.2 region of the patient (from position 62,145,855 to 62,648,232 bp; hg19), and this result was confirmed by FISH analysis ( Fig. 3 ) . The microdeletion was not found in the patient's mother nor son; this was confirmed by FISH.
It was only possible to test the patient's mother (the father had died), and her son had a normal karyotype (46,XY).
In the deleted region, there were 3 OMIM genes: a 3 ′ part of PTPRG (OMIM 176886; https://decipher.sanger. ac.uk/), FEZF2 (OMIM 607414), and a 5 ′ part of CADPS (OMIM 604667) ( Fig. 4 ) 
Discussion
In recent years, submicroscopic deletions/duplications (less than 10 Mb) have been evidenced using array CGH in cases of ID, multiple congenital defects, and dys- The array-CGH profile of chromosome 3 showing the deletion. In the upper part, chromosome 3, generated by CytoChip, is shown. The red bar shows the patient's deletion. The breakpoint of the 3p14.2 deletion is from position 62,145,855 to 62,648,232 bp. The size of the deletion is ∼ 500 kb. In the lower part of the figure, the 3p14.2 deleted region and genes included as generated by the UCSC Genome Browser are shown. The PTPRG , FEZF2 , and CADP genes, partially or completely deleted, are indicated by red circles.
morphisms. The delineation of their size and breakpoints helps to understand the genotype-phenotype correlations of small genomic imbalances [Rauch et al., 2006] .
Our patient, with moderate ID, severe speech delay, and mild dysmorphic features, shows a 500-kb deletion in the 3p14.2 region, spanning from position 62,145,855 to 62,648,232 and containing 3 OMIM genes: FEZF2, CADPS (partially), and PTPRG . C3orf14 was also deleted. The respective codified proteins proved to be linked to brain development and function. The FEZF2 gene (FEZ family zinc finger protein 2) encodes a transcriptional factor necessary for the specification of corticospinal neuron and connectivity [Yang et al., 2012; Wolf and Ryu, 2013] . The CADPS gene (calcium-dependent activator protein for secretion 1) encodes a neuroendocrine-specific cytosolic and peripheral membrane protein that is required for Ca 2+ -regulated exocytosis of the secretory vesicle. This protein is expressed in fetal and adult brain as well as in neuroendocrine tissues, and it is an essential regulator of the synaptic and large core vesicles priming in mammalian neurons as well as in neuroendocrine cells [Brunk et al., 2009; Farina et al., 2015] . The PTPRG gene (protein tyrosine phosphatase, receptor type G) encodes a protein that is a member of the protein tyrosine phosphatase (PTP) family. PTPs are signaling molecules that regulate many cellular processes, including cell growth, differentiation, mitotic cycle, and oncogenic transformation. PTPRG is frequently deleted in renal cell carcinoma and lung carcinoma; thus it is thought to be a candidate tumor suppressor gene [Lamprianou et al., 2006] .
Considering the roles that these 3 genes play in central nervous system development, it is conceivable that their loss may be causative of the pathologic phenotype seen in our patient via haploinsufficiency. This is also supported by assessments with biostatistical analysis [Huang et al., 2010] . A possible interactome network of these 3 proteins is shown in Figure 5 , based on a STRING database search (https://string-db.org/).
In order to substantiate a correlation between genotype and phenotype, we compared our deletion to those already reported in the literature for the same region and in the DECIPHER database (https://decipher.sanger. ac.uk/) [Tao et al., 2011; Schwaibold et al., 2013; Okumura et al., 2014; de la Hoz et al., 2015] ( Table 1 ) .
Our patient shares developmental delay, ID, typical mild facial dysmorphism, and language impairment with all reported cases, but lacks other pathological characteristics such as hypotonia, obesity, autism, or epilepsy which are present in some other deletions.
The 3p14 deletion of our patient is relatively small compared to the majority of the reported cases in this chromosomal region ( Fig. 6 ) ; only FEZF2 and CADPS (partially) are deleted among the genes of the suggested core 3p14.2 region that is considered crucial for the signs and symptoms present in our patient. Haploinsufficiency of the 2 genes in the suspected critical zone [de La Hoz et al., 2015] , alone or in conjunction with the partial loss of PTPRG , whose function is considered important for neurodevelopment, should be sufficient to result in the following characteristics of the 3p-deletion phenotype: developmental delay, ID, mild facial dysmorphisms, and language impairment. Our patient has no autistic features or epilepsy because these disorders could be due to the additional loss of other genes, such as PRICKLE2 and MAGI1 [Okumura et al., 2014] .
The premature ovarian failure present in our patient and her mother was probably due to genetic mutation(s) of other gene(s) in chromosomal loci different from the deleted one in 3p14.2.
Furthermore, considering the smaller size of the deletion involving only CADPS , reported in DECIPHER number 255918, it seems possible that this is sufficient to lead to ID and dysmorphisms, but other similar cases are required to confirm such observation. There is no reported case of a deletion only in the FEZF2 gene with ID and/ or other phenotypic features that could support its importance in pathogenicity. However, the importance of FEZF2 for ID and developmental delay is shown in a recently described patient with a homozygous point mutation in the gene presenting with brain atrophy, suspected Dandy-Walker malformation, and microcephaly detected by cerebral MRI [Anazi et al., 2017] . Finally, the PTPRG tumor suppressor gene, which is outside of the suggested critical region [de la Hoz et al., 2015] and does 180 not seem to be relevant in the determination of ID and dysmorphisms (with a few exceptions) [Kranz et al., 2016] , is also partially involved in our deletion. In our case, there is no behavior alteration, even if the gene is considered a relevant predisposition factor for this [Cressant et al., 2017] .
In conclusion, we believe that the 3p14 microdeletion identified in our patient leads to the observed phenotype due to the loss of at least 2 genes ( FEZF2 and CADPS ) included in the region, already suspected to be responsible for neurological disorders. The deletion of these genes is sufficient to result in ID, speech delay, and mild dysmorphisms, but not autism or epilepsy. Fig. 6 . Schematic representation of the 3p14.2 deletion identified in our patient and in previously described patients in the literature and in the DECIPHER database. The dotted lines contain the region in which the candidate genes are located and the overlapping deleted regions of the other cases.
